GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Albemarle Corp (NYSE:ALB) » Definitions » EBIT

Albemarle (Albemarle) EBIT

: $363 Mil (TTM As of Dec. 2023)
View and export this data going back to 1994. Start your Free Trial

Albemarle's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-887 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $363 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Albemarle's annualized ROC % for the quarter that ended in Dec. 2023 was -29.59%. Albemarle's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -35.59%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Albemarle's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.19%.


Albemarle EBIT Historical Data

The historical data trend for Albemarle's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albemarle Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 620.65 446.64 195.09 2,556.42 362.81

Albemarle Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 887.13 1,184.26 193.95 -128.83 -886.57

Competitive Comparison

For the Specialty Chemicals subindustry, Albemarle's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albemarle EV-to-EBIT Distribution

For the Chemicals industry and Basic Materials sector, Albemarle's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Albemarle's EV-to-EBIT falls into.



Albemarle EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $363 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albemarle  (NYSE:ALB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Albemarle's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-3684.224 * ( 1 - -12.91% )/( (13502.425 + 14614.412)/ 2 )
=-4159.8573184/14058.4185
=-29.59 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18883.354 - 3779.261 - ( 1601.668 - max(0, 3941.612 - 7125.562+1601.668))
=13502.425

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18270.652 - 2766.34 - ( 889.9 - max(0, 3560.462 - 5216.919+889.9))
=14614.412

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Albemarle's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3546.26/( ( (8308.615 + max(1215.889, 0)) + (9632.609 + max(770.268, 0)) )/ 2 )
=-3546.26/( ( 9524.504 + 10402.877 )/ 2 )
=-3546.26/9963.6905
=-35.59 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1179.012 + 3404.212 + 411.926) - (3779.261 + 0 + 0)
=1215.889

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1213.16 + 2161.287 + 330.522) - (2766.34 + 0 + 168.361)
=770.268

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Albemarle's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=362.81/16529.803
=2.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albemarle EBIT Related Terms

Thank you for viewing the detailed overview of Albemarle's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Albemarle (Albemarle) Business Description

Address
4250 Congress Street, Suite 900, Charlotte, NC, USA, 28209
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the U.S. and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the U.S., Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Executives
Kristin M Coleman officer: EVP, General Counsel 140 HAZEL AVE., GLENCOE IL 60022
Neal Ravi Sheorey officer: Chief Financial Officer 4250 CONGRESS STREET, SUITE 900, CHARLOTTE NC 28209
Michael James Simmons officer: President - Ketjen 301 COMMERCE STREET, SUITE 3200, FORT WORTH TX 76102
Eric Norris officer: President, Lithium 1519 AUDUBON ROAD, CHARLOTTE NC 28211
J Kent Masters director ALBEMARLE CORP., 451 FLORIDA ST, BATON ROUGE LA 70801
Sean B. O'hollaren officer: Chief External Affairs Officer 4250 CONGRESS STREET, SUITE 900, CHARLOTTE NC 28209
Jacobus G. Fourie officer: Chief Capital Projects Officer 4250 CONGRESS STREET, SUITE 900, CHARLOTTE NC 28209
Scott Tozier officer: EVP & CFO ALBEMARLE CORP, 4250 CONGRESS ST STE 900, CHARLOTTE NC 28209
Karen G Narwold officer: EVP, Chief Admin Officer ALBEMARLE CORPORATION, 4250 CONGRESS ST, SUITE 900, CHARLOTTE NC 28209
Raphael Goszcz Crawford officer: President, Catalysts 4311 GREENBRIAR HILLS PLANTATION RD, CHARLOTTE NC 28277
Ralf Hans Cramer director MIERENDORSFSTRASSE 26, BENSHEIM 2M 64625
Netha N. Johnson officer: President, Bromine Specialties 3489 CRESTMOOR DRIVE, WOODBURY MN 55125
Barichivich John Clarence Iii officer: VP, Controller & CAO 4250 CONGRESS ST., SUITE 900, CHARLOTTE NC 28209
Kissam Luther C Iv director, officer: Chairman, President & CEO 3801 BERESFORD ROAD, CHARLOTTE NC 28211
Melissa H. Anderson officer: SVP, Chief HR Officer ALBEMARLE CORPORATION, 4250 CONGRESS ST. SUITE 900, CHARLOTTE NC 28209